---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-083284"
form_type: "8-K"
ticker: "RANI"
cik: "0001856725"
company_name: "Rani Therapeutics Holdings, Inc."
filed_at: "2024-07-12T23:59:59+00:00"
generated_at: "2026-05-31T21:26:01.620356+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "medium"
source: SEC EDGAR
---

# Rani Therapeutics decides not to pursue equity financing after investor talks

## Summary
- Engaged in discussions with investors for a potential equity financing but elected not to proceed.
- Decision based on evaluation of business development, cash position, outlook, and market conditions.
- Company will continue to assess cash needs and may seek equity financing in the future.
- No specific numbers or financial guidance provided in the filing.

## SEC filing metadata
- accession: 0000950170-24-083284
- form_type: 8-K
- ticker: RANI
- cik: 0001856725
- company_name: Rani Therapeutics Holdings, Inc.
- filed_at: 2024-07-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: medium
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1856725/000095017024083284/0000950170-24-083284-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1856725/000095017024083284/rani-20240712.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-083284
- JSON: https://secwatch.observer/filing/0000950170-24-083284.json
- Plain text: https://secwatch.observer/filing/0000950170-24-083284.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.